An Early Response Transcription Factor, Egr-1, Enhances Insulin Resistance in Type 2 Diabetes with Chronic Hyperinsulinism
| Autor: | Chao-Jun Li, Fei-Yan Pan, Xiao Yu, Ning Shen, Xiang Gao, Bin Xue |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Male
medicine.medical_specialty Transcription Genetic MAP Kinase Signaling System medicine.medical_treatment Type 2 diabetes Biochemistry Mice chemistry.chemical_compound Insulin resistance Hyperinsulinism Insulin receptor substrate Internal medicine Adipocytes medicine Animals Farnesyltranstransferase Humans Insulin Phosphorylation Molecular Biology Early Growth Response Protein 1 biology Geranyltranstransferase Tyrosine phosphorylation 3T3 Cells Cell Biology Dimethylallyltranstransferase medicine.disease Insulin oscillation body regions Insulin receptor Endocrinology Diabetes Mellitus Type 2 chemistry biology.protein Insulin Resistance |
| Zdroj: | Journal of Biological Chemistry. 286:14508-14515 |
| ISSN: | 0021-9258 |
| DOI: | 10.1074/jbc.m110.190165 |
| Popis: | One of the most important characteristics of type 2 diabetes is insulin resistance, during which the patients normally experienced hyperinsulinism stress that would alter insulin signal transduction in insulin target tissues. We have previously found that early growth responsive gene-1 (Egr-1), a zinc finger transcription factor, is highly expressed in db/db mice and in the fat tissue of individuals with type 2 diabetes. In this report, we found that chronic exposure to hyperinsulinism caused persistent Erk/MAPK activity in adipocytes and enhanced insulin resistance in an Egr-1-dependent manner. An elevation in Egr-1 augmented Erk1/2 activation via geranylgeranyl diphosphate synthase (GGPPS). Egr-1-promoted GGPPS transcription increased Ras prenylation and caused Erk1/2 activation. The sustained activation of Erk1/2 resulted in the phosphorylation of insulin receptor substrate-1 at Serine 612. Phosphorylation at this site impaired insulin signaling in adipocytes and reduced glucose uptake. The loss of Egr-1 function, knockdown of GGPPS, or inhibition of Erk1/2 activity in insulin-resistant adipocytes restored insulin receptor substrate-1 tyrosine phosphorylation and increased insulin sensitivity. Our results suggest a new mechanism by which the Egr-1/GGPPS/Erk1/2 pathway is responsible for insulin resistance during hyperinsulinism. This pathway provides a new therapeutic target for increasing insulin sensitivity: inhibiting the function of Egr-1. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|